New bladder irrigation device aims to cut Post-Surgery infections
NCT ID NCT07510685
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested a closed-system bladder irrigation device designed to reduce urinary tract infections after endoscopic urologic surgery. 240 patients undergoing prostate or bladder tumor surgery were randomly assigned to use the new device or standard irrigation. The device allows healthcare workers to flush the bladder without opening the catheter system, potentially lowering contamination. The main goal was to see if it reduced bacteria in the urine.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Closed-system bladder irrigation flow switch device
- What this could lead to
- If it works, this device could lower infection rates after bladder surgery, reducing the need for antibiotics and speeding recovery.
- What could go wrong
- This is a single-center trial with 240 patients, so results may not apply to all hospitals. The device may not significantly reduce infections compared to standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
240 people
The number who actually took part.
- Started
-
Feb 2025
- Finished
-
Dec 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 18 years or older * Patients undergoing endoscopic urologic surgery (transurethral resection of the prostate or transurethral resection of bladder tumor) * Patients requiring postoperative continuous bladder irrigation * Ability to provide written informed consent Exclusion Criteria: * Pre-existing urinary tract infection or bacteriuria prior to surgery * Known contraindication to urinary catheterization or bladder irrigation * Patients undergoing emergency surgery * Inability to provide informed consent
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Benign prostatic hyperplasia are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Azienda Ospedaliero Universitaria Pisana
Pisa, Tuscany, 56100, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Dutch bladder cancer cohort aims to map survival and recurrence
- One surgery or two? trial tests prostate removal during bladder stone operation
- Can two drugs plus chemoradiation let bladder cancer patients keep their bladder?
- Lab-Grown tumor organoids could pick the right bladder chemo
- Can tumor genes decide who keeps their bladder?
- Lab-Grown tumor models could match patients to the right cancer drug